BQ Prime's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BQ Prime's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Prabhudas Lilladher Report
Max Healthcare Institute Ltd.'s Q3 FY23 Ebitda came above our estimates by 6%, aided by better occupancy (77% in Q3 versus 78% in Q2) in a seasonally weak quarter. Max Healthcare has shown phenomenal growth in past two years and we expect this momentum to continue given-
strong expansion plans (up 1500 additional beds by FY25E end),
improving payor mix (15% revenue contribution from institutional by FY25E versus 17% now) and
scale up in labs.
Max Healthcare Institute's operational efficiency has also been commendable, especially in competitive markets like National capital region. We expect 14% Ebitda compound annual growth rate over FY23-25E.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
